Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Debt Ratio (2018 - 2025)

Akebia Therapeutics (AKBA) has disclosed Debt Ratio for 8 consecutive years, with 0.13 as the latest value for Q4 2025.

  • Quarterly Debt Ratio fell 26.93% to 0.13 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.13 through Dec 2025, down 26.93% year-over-year, with the annual reading at 0.13 for FY2025, 26.93% down from the prior year.
  • Debt Ratio for Q4 2025 was 0.13 at Akebia Therapeutics, down from 0.13 in the prior quarter.
  • The five-year high for Debt Ratio was 0.19 in Q4 2022, with the low at 0.13 in Q4 2025.
  • Average Debt Ratio over 5 years is 0.16, with a median of 0.16 recorded in 2021.
  • The sharpest move saw Debt Ratio soared 59.11% in 2021, then dropped 29.34% in 2025.
  • Over 5 years, Debt Ratio stood at 0.18 in 2021, then rose by 0.71% to 0.19 in 2022, then fell by 22.68% to 0.14 in 2023, then grew by 22.2% to 0.18 in 2024, then fell by 26.93% to 0.13 in 2025.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.13, 0.13, and 0.14 for Q4 2025, Q3 2025, and Q2 2025 respectively.